Top

Published in:

01-06-2018 | What's New in Intensive Care

What’s new in cardiorenal syndrome?

Authors: Michael Darmon, Miet Schetz

Published in: Intensive Care Medicine | Issue 6/2018

Excerpt

Cardiorenal syndrome (CRS) is a bidirectional disorder in which heart and kidney may induce or perpetuate disease in the other organ [1, 2]. Five subtypes reflecting the primary dysfunction and its chronicity have been described. This “what’s new” paper will focus on CRS type 1 in which acute heart failure (AHF) (mostly in the setting of cardiogenic shock or acute decompensated heart failure) induces renal dysfunction and/or injury. CRS type 1 is common, may affect 25–33% of patients with AHF, and is associated with a grim prognosis [2, 3]. …

Available only for authorised users

Schefold JC, Filippatos G, Hasenfuss G et al (2016) Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 12:610–623. https://doi.org/10.1038/nrneph.2016.113 CrossRefPubMed

Haase M, Müller C, Damman K et al (2013) Pathogenesis of cardiorenal syndrome type 1 in acute decompensated heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 182:99–116. https://doi.org/10.1159/000349969 CrossRefPubMed

Dar O, Cowie MR (2008) Acute heart failure in the intensive care unit: epidemiology. Crit Care Med 36:S3–S8. https://doi.org/10.1097/01.CCM.0000296264.41365.80 CrossRefPubMed

Chen C, Lee J, Johnson AE et al (2017) Right ventricular function, peripheral edema, and acute kidney injury in critical illness. Kidney Int Rep 2:1059–1065. https://doi.org/10.1016/j.ekir.2017.05.017 CrossRefPubMedPubMedCentral

Mullens W, Abrahams Z, Skouri HN et al (2008) Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol 51:300–306. https://doi.org/10.1016/j.jacc.2007.09.043 CrossRefPubMed

Grande D, Terlizzese P, Iacoviello M (2017) Role of imaging in the evaluation of renal dysfunction in heart failure patients. World J Nephrol 6:123–131. https://doi.org/10.5527/wjn.v6.i3.123 CrossRefPubMedPubMedCentral

van Vark LC, Lesman-Leegte I, Baart SJ et al (2017) Prognostic value of serial ST2 measurements in patients with acute heart failure. J Am Coll Cardiol 70:2378–2388. https://doi.org/10.1016/j.jacc.2017.09.026 CrossRefPubMed

Shirakabe A, Hata N, Kobayashi N et al (2018) Worsening renal function definition is insufficient for evaluating acute renal failure in acute heart failure. ESC Heart Fail. https://doi.org/10.1002/ehf2.12264 PubMedPubMedCentralCrossRef

Brisco MA, Zile MR, Hanberg JS et al (2016) Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial. J Card Fail 22:753–760. https://doi.org/10.1016/j.cardfail.2016.06.423 CrossRefPubMedPubMedCentral

10.

Vaduganathan M, Greene SJ, Fonarow GC et al (2014) Hemoconcentration-guided diuresis in heart failure. Am J Med 127:1154–1159. https://doi.org/10.1016/j.amjmed.2014.06.009 CrossRefPubMed

11.

Ahmad T, Jackson K, Rao VS et al (2018) Worsening renal function in acute heart failure patients undergoing aggressive diuresis is not associated with tubular injury. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.117.030112 CrossRefPubMed

12.

Legrand M, De Berardinis B, Gaggin HK et al (2014) Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One 9:e112313. https://doi.org/10.1371/journal.pone.0112313 CrossRefPubMedPubMedCentral

13.

Damman K, Valente MAE, van Veldhuisen DJ et al (2017) Plasma neutrophil gelatinase-associated lipocalin and predicting clinically relevant worsening renal function in acute heart failure. Int J Mol Sci. https://doi.org/10.3390/ijms18071470 PubMedPubMedCentralCrossRef

14.

Maisel AS, Wettersten N, van Veldhuisen DJ et al (2016) Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol 68:1420–1431. https://doi.org/10.1016/j.jacc.2016.06.055 CrossRefPubMed

15.

Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975. https://doi.org/10.1002/ejhf.592 CrossRefPubMed

16.

Ishihara S, Gayat E, Sato N et al (2016) Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure. Clin Res Cardiol 105:971–980. https://doi.org/10.1007/s00392-016-1009-6 CrossRefPubMed

17.

Fedele F, Karason K, Matskeplishvili S (2017) Pharmacological approaches to cardio-renal syndrome: a role for the inodilator levosimendan. Eur Heart J Suppl 19:C22–C28. https://doi.org/10.1093/eurheartj/sux002 CrossRefPubMedPubMedCentral

18.

Grodin JL, Stevens SR, de Las Fuentes L et al (2016) Intensification of medication therapy for cardiorenal syndrome in acute decompensated heart failure. J Card Fail 22:26–32. https://doi.org/10.1016/j.cardfail.2015.07.007 CrossRefPubMed

19.

McMurray JJV, Packer M, Desai AS et al (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993–1004. https://doi.org/10.1056/NEJMoa1409077 CrossRefPubMed

Title: What’s new in cardiorenal syndrome?
Authors: Michael Darmon
Miet Schetz
Publication date: 01-06-2018
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 6/2018
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-018-5190-0

ACC 2024 Congress

Springer Medicine

What’s new in cardiorenal syndrome?

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2018

There’s more to medicine than machines

Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients

Does this patient with thrombotic thrombocytopenic purpura have a cardiac involvement?

Traumatic cardiac luxation

The first report of safety and feasibility of transbronchial cryoprobe lung biopsy in ARDS

The clinical features of cardiac involvement in patients with severe thrombotic thrombocytopenic purpura